Dr. Jean-Yves Douillard: We Should No Longer Consider NSCLC as a Single Disease
Dr. Jean-Yves Douillard: We Should No Longer Consider NSCLC as a Single Disease
Jean-Yves Douillard, MD
20120019
2012 Jan 19
Interview by L Scott Zoeller
Dr. Jean-Yves Douillard: We Should No Longer Consider NSCLC as a Single Disease
Interview by L Scott Zoeller. 2012 Jan 19, Jean-Yves Douillard, MD
To mark 2011, we have asked our distinguished OncologySTAT Advisory Board Members to choose their top story of the year. In this interview, Dr. Jean-Yves Douillard discusses his choice in NSCLC. OncologySTAT: Which development in 2011 in lung cancer could have the most significant impact in oncology?Dr. Douillard: I think that the continuous identification of biomarkers and the use of targeted therapy is the most significant story in lung cancer for 2011. We already have a variety of drugs to use...
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
